It has been reported that histone acetylation is also implicated in GC resistance in patients with chronic obstructive pulmonary disease (COPD) and asthma [12, 13], as a result of decreased HDAC activity leading to a reduction in the level of deacetylated histones. The gene discussed is HDAC9; the disease is chronic obstructive pulmonary disease.